{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:04:20Z","timestamp":1790276660992,"version":"4.1.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.berh.2011.10.020","type":"journal-article","created":{"date-parts":[[2011,12,8]],"date-time":"2011-12-08T17:52:04Z","timestamp":1323366724000},"page":"735-747","source":"Crossref","is-referenced-by-count":70,"title":["Hyperphosphatemic familial tumoral calcinosis (FGF23, GALNT3 and \u03b1Klotho)"],"prefix":"10.1016","volume":"25","author":[{"given":"Emily G.","family":"Farrow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik A.","family":"Imel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth E.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2011.10.020_bib1","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1172\/JCI114043","article-title":"Physiologic regulation of the serum concentration of 1,25-dihydroxyvitamin D by phosphorus in normal men","volume":"83","author":"Portale","year":"1989","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.berh.2011.10.020_bib2","series-title":"The kidney: physiology and pathophysiology","author":"Berndt","year":"1992"},{"key":"10.1016\/j.berh.2011.10.020_bib3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1152\/physrev.1986.66.1.36","article-title":"Cellular mechanisms of inorganic phosphate transport in kidney","volume":"66","author":"Gmaj","year":"1986","journal-title":"Physiological Reviews"},{"key":"10.1016\/j.berh.2011.10.020_bib4","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1152\/physrev.1985.65.2.431","article-title":"Renal handling of phosphate","volume":"65","author":"Mizgala","year":"1985","journal-title":"Physiological Reviews"},{"key":"10.1016\/j.berh.2011.10.020_bib5","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.1073\/pnas.95.9.5372","article-title":"Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities","volume":"95","author":"Beck","year":"1998","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.berh.2011.10.020_bib6","first-page":"F527","article-title":"Differential expression, abundance, and regulation of Na+-phosphate cotransporter genes in murine kidney","volume":"275","author":"Tenenhouse","year":"1998","journal-title":"American Journal of Physiology"},{"key":"10.1016\/j.berh.2011.10.020_bib7","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1681\/ASN.2008020177","article-title":"Type IIc sodium-dependent phosphate transporter regulates calcium metabolism","volume":"20","author":"Segawa","year":"2009","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1016\/j.berh.2011.10.020_bib8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1086\/499409","article-title":"SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis","volume":"78","author":"Bergwitz","year":"2006","journal-title":"The American Journal of Human Genetics"},{"key":"10.1016\/j.berh.2011.10.020_bib9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/81664","article-title":"Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23","volume":"26","author":"ADHR-Consortium","year":"2000","journal-title":"Nature Genetics"},{"key":"10.1016\/j.berh.2011.10.020_bib10","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI18399","article-title":"FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting","volume":"112","author":"Riminucci","year":"2003","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.berh.2011.10.020_bib11","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1046\/j.1523-1755.2001.00064.x","article-title":"Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23","volume":"60","author":"White","year":"2001","journal-title":"Kidney International"},{"key":"10.1016\/j.berh.2011.10.020_bib12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00774-009-0111-5","article-title":"An autosomal dominant hypophosphatemic rickets phenotype in a Tunisian family caused by a new FGF23 missense mutation","volume":"28","author":"Gribaa","year":"2010","journal-title":"Journal of Bone and Mineral Metabolism"},{"key":"10.1016\/j.berh.2011.10.020_bib13","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1210\/en.143.8.3179","article-title":"Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in\u00a0vivo","volume":"143","author":"Shimada","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.berh.2011.10.020_bib14","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/ng1905","article-title":"Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism","volume":"38","author":"Feng","year":"2006","journal-title":"Nature Genetics"},{"key":"10.1016\/j.berh.2011.10.020_bib15","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/ng1868","article-title":"DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis","volume":"38","author":"Lorenz-Depiereux","year":"2006","journal-title":"Nature Genetics"},{"key":"10.1016\/j.berh.2011.10.020_bib16","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.bone.2011.06.029","article-title":"A patient with hypophosphatemic rickets and ossification of posterior longitudinal ligament caused by a novel homozygous mutation in ENPP1 gene","volume":"49","author":"Saito","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.berh.2011.10.020_bib17","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/1097-0142(19870415)59:8<1442::AID-CNCR2820590810>3.0.CO;2-Q","article-title":"Phosphaturic mesenchymal tumors. A polymorphous group causing osteomalacia or rickets","volume":"59","author":"Weidner","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.berh.2011.10.020_bib18","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1210\/en.2003-1768","article-title":"Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis","volume":"145","author":"Larsson","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.berh.2011.10.020_bib19","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.bbrc.2003.12.102","article-title":"FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa","volume":"314","author":"Shimada","year":"2004","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.berh.2011.10.020_bib20","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1210\/en.143.2.587","article-title":"Dietary phosphorus transcriptionally regulates 25-hydroxyvitamin D-1alpha-hydroxylase gene expression in the proximal renal tubule","volume":"143","author":"Zhang","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.berh.2011.10.020_bib21","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1210\/en.2004-0233","article-title":"Transgenic mice overexpressing human fibroblast growth factor 23(R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders","volume":"145","author":"Bai","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.berh.2011.10.020_bib22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1677\/JOE-07-0267","article-title":"Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells","volume":"195","author":"Krajisnik","year":"2007","journal-title":"Journal of Endocrinology"},{"key":"10.1016\/j.berh.2011.10.020_bib23","first-page":"4003","article-title":"The parathyroid is a target organ for FGF23 in rats","volume":"117","author":"Ben-Dov","year":"2007","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.berh.2011.10.020_bib24","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1002\/ajmg.a.31947","article-title":"Two novel GALNT3 mutations in familial tumoral calcinosis","volume":"143","author":"Garringer","year":"2007","journal-title":"American Journal of Medical Genetics"},{"key":"10.1016\/j.berh.2011.10.020_bib25","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1210\/jc.2004-2238","article-title":"A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis","volume":"90","author":"Larsson","year":"2005","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.berh.2011.10.020_bib26","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/hmg\/ddi034","article-title":"An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia","volume":"14","author":"Benet-Pages","year":"2005","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.berh.2011.10.020_bib27","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1210\/jc.2002-021105","article-title":"Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia","volume":"87","author":"Yamazaki","year":"2002","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.berh.2011.10.020_bib28","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa020881","article-title":"Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia","volume":"348","author":"Jonsson","year":"2003","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.berh.2011.10.020_bib29","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1210\/jc.2005-2105","article-title":"Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia","volume":"91","author":"Imel","year":"2006","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.berh.2011.10.020_bib30","doi-asserted-by":"crossref","first-page":"5523","DOI":"10.1210\/jc.2005-0301","article-title":"A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis","volume":"90","author":"Araya","year":"2005","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.berh.2011.10.020_bib31","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1210\/en.2005-0431","article-title":"Fibroblast growth factor-23 mutants causing familial tumoral calcinosis are differentially processed","volume":"146","author":"Larsson","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.berh.2011.10.020_bib32","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","article-title":"Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism","volume":"113","author":"Shimada","year":"2004","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.berh.2011.10.020_bib33","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.matbio.2004.09.007","article-title":"Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice","volume":"23","author":"Sitara","year":"2004","journal-title":"Matrix Biology"},{"key":"10.1016\/j.berh.2011.10.020_bib34","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ng1358","article-title":"Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis","volume":"36","author":"Topaz","year":"2004","journal-title":"Nature Genetics"},{"key":"10.1016\/j.berh.2011.10.020_bib35","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1210\/jc.2006-0305","article-title":"The role of mutant UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase 3 in regulating serum intact fibroblast growth factor 23 and matrix extracellular phosphoglycoprotein in heritable tumoral calcinosis","volume":"91","author":"Garringer","year":"2006","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.berh.2011.10.020_bib36","doi-asserted-by":"crossref","first-page":"18370","DOI":"10.1074\/jbc.M602469200","article-title":"Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. secretion of fibroblast growth factor 23 requires O-glycosylation","volume":"281","author":"Kato","year":"2006","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.berh.2011.10.020_bib37","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1210\/jc.2006-1247","article-title":"Tumoral calcinosis presenting with eyelid calcifications due to novel missense mutations in the glycosyl transferase domain of the GALNT3 gene","volume":"91","author":"Ichikawa","year":"2006","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.berh.2011.10.020_bib38","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1359\/jbmr.061105","article-title":"Hyperostosis-hyperphosphatemia syndrome: a congenital disorder of O-glycosylation associated with augmented processing of fibroblast growth factor 23","volume":"22","author":"Frishberg","year":"2007","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.berh.2011.10.020_bib39","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1210\/en.2008-0877","article-title":"Ablation of the Galnt3 gene leads to low-circulating intact fibroblast growth factor 23 (Fgf23) concentrations and hyperphosphatemia despite increased Fgf23 expression","volume":"150","author":"Ichikawa","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.berh.2011.10.020_bib40","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1046\/j.1523-1755.2003.00328.x","article-title":"Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers","volume":"64","author":"Larsson","year":"2003","journal-title":"Kidney International"},{"key":"10.1016\/j.berh.2011.10.020_bib41","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1210\/jc.2004-1039","article-title":"Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men","volume":"90","author":"Ferrari","year":"2005","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.berh.2011.10.020_bib42","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1359\/jbmr.060507","article-title":"Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women","volume":"21","author":"Burnett","year":"2006","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.berh.2011.10.020_bib43","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.bone.2005.03.002","article-title":"Genetic dissection of phosphate- and vitamin D-mediated regulation of circulating Fgf23 concentrations","volume":"36","author":"Yu","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.berh.2011.10.020_bib44","doi-asserted-by":"crossref","first-page":"E1101","DOI":"10.1152\/ajpendo.00502.2004","article-title":"Vitamin D and phosphate regulate fibroblast growth factor-23 in K-562 cells","volume":"288","author":"Ito","year":"2005","journal-title":"American Journal of Physiology-Endocrinology and Metabolism"},{"key":"10.1016\/j.berh.2011.10.020_bib45","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.berh.2011.10.020_bib46","doi-asserted-by":"crossref","first-page":"G1036","DOI":"10.1152\/ajpgi.00243.2005","article-title":"1alpha,25-dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport","volume":"289","author":"Kolek","year":"2005","journal-title":"American Journal of Physiology-Gastrointestinal and Liver Physiology"},{"key":"10.1016\/j.berh.2011.10.020_bib47","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1210\/jc.2009-0961","article-title":"Defective O-glycosylation due to a novel homozygous S129P mutation is associated with lack of fibroblast growth factor 23 secretion and tumoral calcinosis","volume":"94","author":"Bergwitz","year":"2009","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.berh.2011.10.020_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/gb-2001-2-3-reviews3005","article-title":"Fibroblast growth factors","volume":"2","author":"Ornitz","year":"2001","journal-title":"Genome Biology"},{"key":"10.1016\/j.berh.2011.10.020_bib49","doi-asserted-by":"crossref","first-page":"26687","DOI":"10.1074\/jbc.M704165200","article-title":"Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21","volume":"282","author":"Kurosu","year":"2007","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.berh.2011.10.020_bib50","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1247\/csf.29.91","article-title":"Immunohistochemical localization of Klotho protein in brain, kidney, and reproductive organs of mice","volume":"29","author":"Li","year":"2004","journal-title":"Cell Structure and Function"},{"key":"10.1016\/j.berh.2011.10.020_bib51","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/36285","article-title":"Mutation of the mouse klotho gene leads to a syndrome resembling ageing","volume":"390","author":"Kuro-o","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.berh.2011.10.020_bib52","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1006\/bbrc.1997.8019","article-title":"Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein","volume":"242","author":"Matsumura","year":"1998","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.berh.2011.10.020_bib53","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0014-5793(98)00127-6","article-title":"Structure of the mouse klotho gene and its two transcripts encoding membrane and secreted protein","volume":"424","author":"Shiraki-Iida","year":"1998","journal-title":"FEBS Letters"},{"key":"10.1016\/j.berh.2011.10.020_bib54","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1074\/jbc.C500457200","article-title":"Regulation of fibroblast growth factor-23 signaling by klotho","volume":"281","author":"Kurosu","year":"2006","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.berh.2011.10.020_bib55","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1677\/JOE-10-0181","article-title":"Altered renal FGF23-mediated activity involving MAPK and Wnt: effects of the Hyp mutation","volume":"207","author":"Farrow","year":"2010","journal-title":"The Journal of Endocrinology"},{"issue":"7120","key":"10.1016\/j.berh.2011.10.020_bib56","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","article-title":"Klotho converts canonical FGF receptor into a specific receptor for FGF23","volume":"444","author":"Urakawa","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.berh.2011.10.020_bib57","doi-asserted-by":"crossref","first-page":"E508","DOI":"10.1152\/ajpendo.00499.2010","article-title":"Compound deletion of Fgfr3 and Fgfr4 partially rescues the Hyp mouse phenotype","volume":"300","author":"Li","year":"2011","journal-title":"American Journal of Physiology Endocrinology and Metabolism"},{"key":"10.1016\/j.berh.2011.10.020_bib58","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","article-title":"Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia","volume":"98","author":"Shimada","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.berh.2011.10.020_bib59","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1172\/JCI31330","article-title":"A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis","volume":"117","author":"Ichikawa","year":"2007","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.berh.2011.10.020_bib60","first-page":"1114","article-title":"Ectopic calcification in Klotho mice","volume":"12","author":"Nabeshima","year":"2002","journal-title":"Clinical Calcium"},{"key":"10.1016\/j.berh.2011.10.020_bib61","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1210\/me.2003-0048","article-title":"a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system","volume":"17","author":"Tsujikawa","year":"2003","journal-title":"Molecular Endocrinology (Baltimore, Md)"},{"key":"10.1016\/j.berh.2011.10.020_bib62","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S0022-3476(81)80013-3","article-title":"The syndrome of hyperostosis and hyperphosphatemia","volume":"99","author":"Mikati","year":"1981","journal-title":"The Journal of Pediatrics"},{"key":"10.1016\/j.berh.2011.10.020_bib63","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00109-004-0610-8","article-title":"Identification of a recurrent mutation in GALNT3 demonstrates that hyperostosis-hyperphosphatemia syndrome and familial tumoral calcinosis are allelic disorders","volume":"83","author":"Frishberg","year":"2005","journal-title":"Journal of Molecular Medicine"},{"key":"10.1016\/j.berh.2011.10.020_bib64","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/ajmg.a.33337","article-title":"Clinical variability of familial tumoral calcinosis caused by novel GALNT3 mutations","volume":"152A","author":"Ichikawa","year":"2010","journal-title":"American Journal of Medical Genetics. Part A"},{"key":"10.1016\/j.berh.2011.10.020_bib65","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0002-9343(65)90164-6","article-title":"Tumoral calcinosis: A metabolic disease of obscure etiology","volume":"38","author":"Lafferty","year":"1965","journal-title":"The American Journal of Medicine"},{"key":"10.1016\/j.berh.2011.10.020_bib66","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00774-011-0260-1","article-title":"Novel mutations in GALNT3 causing hyperphosphatemic familial tumoral calcinosis","volume":"29","author":"Yancovitch","year":"2011","journal-title":"Journal of Bone and Mineral Metabolism"},{"key":"10.1016\/j.berh.2011.10.020_bib67","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/archinte.167.9.879","article-title":"Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community","volume":"167","author":"Dhingra","year":"2007","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.berh.2011.10.020_bib68","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Gutierrez","year":"2008","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.berh.2011.10.020_bib69","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1161\/CIRCULATIONAHA.105.553198","article-title":"Relation between serum phosphate level and cardiovascular event rate in people with coronary disease","volume":"112","author":"Tonelli","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.berh.2011.10.020_bib70","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1681\/ASN.2006121385","article-title":"Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice","volume":"18","author":"Stubbs","year":"2007","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1016\/j.berh.2011.10.020_bib71","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.2106\/00004623-198971080-00019","article-title":"Tumoral calcinosis: successful medical treatment. a case report","volume":"71","author":"Gregosiewicz","year":"1989","journal-title":"The Journal of Bone and Joint Surgery American Volume"},{"key":"10.1016\/j.berh.2011.10.020_bib72","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1210\/jcem-56-6-1319","article-title":"Hyperphosphatemic tumoral calcinosis: effects of phosphate depletion on vitamin D metabolism, and of acute hypocalcemia on parathyroid hormone secretion and action","volume":"56","author":"Lufkin","year":"1983","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.berh.2011.10.020_bib73","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1210\/jcem-50-4-648","article-title":"Phosphorus excretion in tumoral calcinosis: response to parathyroid hormone and acetazolamide","volume":"50","author":"Lufkin","year":"1980","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.berh.2011.10.020_bib74","doi-asserted-by":"crossref","first-page":"120","DOI":"10.7326\/0003-4819-86-1-120_2","article-title":"Phosphorus deprivation treatment of tumoral calcinosis","volume":"86","author":"Mozaffarian","year":"1977","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.berh.2011.10.020_bib75","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/230949900901700328","article-title":"Medical treatment for tumoral calcinosis with eight years of follow-up: a report of four cases","volume":"17","author":"Alkhooly","year":"2009","journal-title":"Journal of Orthopaedic Surgery (Hong Kong)"},{"key":"10.1016\/j.berh.2011.10.020_bib76","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10545-009-9019-4","article-title":"Tumoral calcinosis","volume":"33","author":"Janssen","year":"2010","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"10.1016\/j.berh.2011.10.020_bib77","doi-asserted-by":"crossref","first-page":"741","DOI":"10.7326\/0003-4819-77-5-741","article-title":"Treatment of tumoral calcinosis with phosphorus deprivation","volume":"77","author":"Mozaffarian","year":"1972","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.berh.2011.10.020_bib78","doi-asserted-by":"crossref","first-page":"247S","DOI":"10.1016\/S8756-3282(95)80001-8","article-title":"Successful treatment of hyperphosphatemic tumoral calcinosis with long-term acetazolamide","volume":"16","author":"Yamaguchi","year":"1995","journal-title":"Bone"},{"key":"10.1016\/j.berh.2011.10.020_bib79","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1515\/jpem.2011.106","article-title":"Hyperphosphatemic tumoral calcinosis: a 10-year follow-up","volume":"24","author":"Alves","year":"2011","journal-title":"Journal of Pediatric Endocrinology and Metabolism"},{"key":"10.1016\/j.berh.2011.10.020_bib80","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1136\/jcp.2005.026369","article-title":"Familial tumoral calcinosis and testicular microlithiasis associated with a new mutation of GALNT3 in a white family","volume":"59","author":"Campagnoli","year":"2006","journal-title":"Journal of Clinical Pathology"},{"key":"10.1016\/j.berh.2011.10.020_bib81","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/ki.1976.100","article-title":"Effect of parathyroid hormone on phosphate reabsorption in the presence of acetazolamide","volume":"10","author":"Knox","year":"1976","journal-title":"Kidney International"},{"key":"10.1016\/j.berh.2011.10.020_bib82","first-page":"1188","article-title":"Effects of acetazolamide on the renal excretion of phosphate in hypoparathyroidism and pseudohypoparathyroidism","volume":"89","author":"Sinha","year":"1977","journal-title":"The Journal of Laboratory and Clinical Medicine"},{"key":"10.1016\/j.berh.2011.10.020_bib83","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF03349921","article-title":"Effects of the acute subcutaneous administration of synthetic salmon calcitonin in tumoral calcinosis","volume":"12","author":"Candrina","year":"1989","journal-title":"Journal of Endocrinological Investigation"},{"key":"10.1016\/j.berh.2011.10.020_bib84","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1055\/s-2007-1018689","article-title":"Phosphaturic action of calcitonin in pseudotumoral calcinosis","volume":"15","author":"Salvi","year":"1983","journal-title":"Hormone and Metabolic Research"},{"key":"10.1016\/j.berh.2011.10.020_bib85","first-page":"963","article-title":"The effect of thyrocalcitonin therapy and phosphate deprivation on tumoral calcinosis","volume":"54","author":"Kallmeyer","year":"1978","journal-title":"South African Medical Journal"},{"key":"10.1016\/j.berh.2011.10.020_bib86","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1210\/jc.75.2.408","article-title":"Normal calcitonin stimulation of serum calcitriol in patients with X-linked hypophosphatemic rickets","volume":"75","author":"Econs","year":"1992","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.berh.2011.10.020_bib87","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1056\/NEJMc1010928","article-title":"Calcitonin administration in X-linked hypophosphatemia","volume":"364","author":"Liu","year":"2011","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.berh.2011.10.020_bib88","first-page":"1837","article-title":"Rapid improvement of calcinosis in juvenile dermatomyositis with alendronate therapy","volume":"32","author":"Ambler","year":"2005","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/j.berh.2011.10.020_bib89","first-page":"135","article-title":"Effectiveness of the treatment with intravenous pamidronate in calcinosis in juvenile dermatomyositis","volume":"28","author":"Marco Puche","year":"2010","journal-title":"Clinical and Experimental Rheumatology"},{"key":"10.1016\/j.berh.2011.10.020_bib90","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jbspin.2009.04.011","article-title":"Complete resolution of universal calcinosis in a patient with juvenile dermatomyositis using pamidronate","volume":"77","author":"Slimani","year":"2010","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.berh.2011.10.020_bib91","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1259\/0007-1285-47-562-734","article-title":"Tumoral calcinosis with sedimentation sign","volume":"47","author":"Hug","year":"1974","journal-title":"The British Journal of Radiology"},{"key":"10.1016\/j.berh.2011.10.020_bib92","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1055\/s-2007-996264","article-title":"Tumoral calcinosis. observations during six years","volume":"12","author":"Leicht","year":"1980","journal-title":"Hormone and Metabolic Research"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694211000957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694211000957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T12:45:52Z","timestamp":1561034752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694211000957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":92,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S1521694211000957"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2011.10.020","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}